|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| RCM | |||||
| EHR | |||||
| Patient engagement | |||||
| Financial Health | |||||
| Patient Care | |||||
| Total revenues | |||||
| Expenses: | |||||
| Costs of revenue (exclusive of amortization and depreciation) | |||||
| RCM | |||||
| EHR | |||||
| Patient engagement | |||||
| Financial Health | |||||
| Patient Care | |||||
| Total costs of revenue (exclusive of amortization and depreciation) | |||||
| Product development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Amortization of acquisition-related intangibles | |||||
| Amortization | |||||
| Depreciation | |||||
| Goodwill impairment | |||||
| Trademark impairment | |||||
| Total expenses | |||||
| Operating income (loss) | |||||
| Other (expense) income: | |||||
| Other income | |||||
| Gain on contingent consideration | |||||
| Loss on extinguishment of debt | |||||
| Interest expense | |||||
| Other (expense) income | |||||
| Total other expense | |||||
| Income (loss) before taxes | |||||
| (Benefit) provision for income taxes | |||||
| Net income (loss) | |||||
| Net income (loss) per share - basic (in dollars per share) | |||||
| Net income (loss) per share - diluted (in dollars per share) | |||||
| Weighted average shares outstanding used in per common share computations: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...